Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
Operating Expenses | 22,130 | 20,246 | 20,855 | 24,012 | 20,032 |
Operating Income | -22,130 | -20,246 | -20,855 | -24,012 | -20,032 |
Other Income | 2,221 | 2,021 | 1,447 | 1,005 | 880 |
Pre-tax Income | -19,909 | -18,225 | -19,408 | -23,007 | -19,152 |
Net Income Continuous | -19,909 | -18,225 | -19,408 | -23,007 | -19,152 |
Net Income | $-19,909 | $-18,225 | $-19,408 | $-23,007 | $-19,152 |
EPS Basic Total Ops | -0.36 | -0.35 | -0.34 | -0.45 | -0.52 |
EPS Basic Continuous Ops | -0.36 | -0.35 | -0.33 | -0.45 | -0.52 |
EPS Diluted Total Ops | -0.36 | -0.35 | -0.34 | -0.45 | -0.52 |
EPS Diluted Continuous Ops | -0.36 | -0.35 | -0.33 | -0.45 | -0.52 |
EPS Diluted Before Non-Recurring Items | -0.36 | -0.35 | -0.34 | -0.45 | -0.52 |
EBITDA(a) | $-22,044 | $-20,160 | $-20,769 | $-23,897 | $-19,918 |